Green Thumb Industries Inc. GTII GTBIF reported its earnings late Wednesday, revealing significant financial achievements for the fourth quarter and full year ended December 31, 2023, including increased profits, enhanced margins and an adjusted EBITDA of $326 million.
Key Highlights
- Fourth-quarter revenue reached $278 million, marking a 7% increase year-over-year.
- Full-year revenue grew to $1.1 billion, up 4% from the previous year.
- GAAP net income for the fourth quarter stood at $3 million, with an annual figure of $36 million.
- Gross profit for the fourth quarter was reported at $142.7 million, translating to a gross margin of 51.3%.
- Adjusted EBITDA for the fourth quarter was $91 million, or 33% of revenue, with a full-year adjusted EBITDA of $326 million, or 31% of revenue.
Financial Overview
Green Thumb Industries, a leading cannabis consumer packaged goods company and owner of RISE Dispensaries, demonstrated exceptional financial performance through the end of 2023.
The company reported a revenue increase to $278 million in the fourth quarter, a 7% rise year-over-year, primarily due to increased sales in Maryland following the legalization of adult-use cannabis in the summer of 2023.
Growth And Operations
The company expanded its reach by opening seven new RISE Dispensaries, six in Florida and one in New York. This expansion contributed to a total of 91 dispensaries across fourteen states.
Significant investments were made in cultivation and production facilities to meet the growing demand for both medical and adult-use cannabis, alongside the development of new product types to engage customers and increase market share.
Financial Health And Capital Allocation
Green Thumb reported $162 million in cash at the end of the quarter.
The company also reported strategic moves in capital allocation by purchasing $25 million of senior debt and $15 million of its Subordinate Voting Shares under its share repurchase program.
An additional $50 million was authorized for the share repurchase program, underscoring the company's commitment to returning value to shareholders.
Why Investors Should Pay Attention To GTI
The transition from a net loss to a GAAP net income of $36 million and a steady revenue increase to $1.1 billion for the full year illustrates a strong turnaround and growing operational efficiency.
The improvement in gross margin to 51.3% for the fourth quarter, coupled with a significant adjusted EBITDA of $326 million or 31% of revenue, signals enhanced profitability and financial health. These figures suggest that GTI is well-positioned for sustained growth.
Furthermore, Green Thumb Industries' strategic focus on economically attractive regions and its successful navigation of states transitioning from medical to recreational cannabis sales underscores its potential.
Meanwhile, the company's proactive approach in states like Connecticut, Maryland, New Jersey and Rhode Island, coupled with its readiness for shifts in medical markets toward recreational use, positions it favorably in the rapidly evolving cannabis landscape.
According to senior analyst Pablo Zuanic, Green Thumb's emphasis on owning a diverse portfolio of brands has played an important role in capturing significant market share across key states, highlighting its ability to leverage brand equity to foster customer loyalty and drive sales.
The Benzinga Cannabis Capital Conference is returning to Florida in a new Hollywood venue on April 16 and 17, 2024. The two-day event at The Diplomat Beach Resort will be a chance for entrepreneurs, both large and small, to network, learn, and grow. Renowned for its trendsetting abilities and influence on the future of cannabis, mark your calendars – this conference is the go-to event of the year for the cannabis world.
Get your tickets now on bzcannabis.com – Prices will increase very soon!
Photo: AI-Generated Image.
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Comments
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Cannabis is evolving – don’t get left behind!
Curious about what’s next for the industry and how to leverage California’s unique market?
Join top executives, policymakers, and investors at the Benzinga Cannabis Market Spotlight in Anaheim, CA, at the House of Blues on November 12. Dive deep into the latest strategies, investment trends, and brand insights that are shaping the future of cannabis!
Get your tickets now to secure your spot and avoid last-minute price hikes.